Recovery of the in vivo cytotoxic T-cell response in cyclophosphamide-treated mice by injection of mixed-lymphocyte-culture supernatants
- PMID: 6790167
Recovery of the in vivo cytotoxic T-cell response in cyclophosphamide-treated mice by injection of mixed-lymphocyte-culture supernatants
Abstract
Mice given injections of high antileukemic doses of cyclophosphamide lost the capacity to generate cytotoxic T-cells in vivo to allogeneic tumor cells. These low responses were not due to the elimination of cytotoxic T-lymphocyte precursors because normal cytotoxic responses were obtained in vivo after cyclophosphamide treatment by injection of helper factor derived from mixed-lymphocyte-culture supernatants.
Similar articles
-
Inhibition of cytotoxic T-cell clonal expansion by cyclophosphamide and the recovery of cytotoxic T-lymphocyte precursors by supernatants from mixed-lymphocyte cultures.Cancer Res. 1981 Mar;41(3):850-3. Cancer Res. 1981. PMID: 6450638
-
Restoration of cyclophosphamide-induced suppression of thymus-derived cytotoxic cell generation by normal thymocytes.Cancer Res. 1979 Sep;39(9):3647-54. Cancer Res. 1979. PMID: 157806
-
The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro.Immunology. 1983 Mar;48(3):433-8. Immunology. 1983. PMID: 6219062 Free PMC article.
-
Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.Cancer Res. 1982 Feb;42(2):397-404. Cancer Res. 1982. PMID: 7055792
-
Characteristics of an antigen-specific helper factor that enhances the in vitro generation of cytotoxic cells directed against a syngeneic tumor.J Immunol. 1981 Dec;127(6):2465-9. J Immunol. 1981. PMID: 6170706
Cited by
-
Enhancement of interleukin-2 release in rats by treatment with bleomycin and adriamycin in vivo.Cancer Immunol Immunother. 1987;25(3):245-9. doi: 10.1007/BF00199154. Cancer Immunol Immunother. 1987. PMID: 2445487 Free PMC article.
-
Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed mice.J Virol. 1984 Jul;51(1):20-5. doi: 10.1128/JVI.51.1.20-25.1984. J Virol. 1984. PMID: 6610060 Free PMC article.
-
Cytochalasin-B-induced immunosuppression of murine allogeneic anti-tumor response and the effect of recombinant human interleukin-2.Cancer Immunol Immunother. 1991;32(6):400-5. doi: 10.1007/BF01741335. Cancer Immunol Immunother. 1991. PMID: 1901032 Free PMC article.
-
Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice.Pharm Res. 1992 Mar;9(3):425-34. doi: 10.1023/a:1015815624334. Pharm Res. 1992. PMID: 1614979
-
Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.J Exp Med. 1985 May 1;161(5):1169-88. doi: 10.1084/jem.161.5.1169. J Exp Med. 1985. PMID: 3886826 Free PMC article.